Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lovaza for Parenteral Nutrition-associated Liver Disease
NCT01191177Phase 2Withdrawn
- Sponsor
- Boston Children's Hospital
- Start
- Jan 2011
- Primary completion
- Jan 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in Parenteral Nutrition Associated Liver Disease (PNALD) comparing Lovaza group with Placebo group (2 arms). Primary endpoint: Normalization of Alanine Aminotransferase. Planned start Jan 2011; status: withdrawn.
02
Drugs
eicosapentaenoic acid + docosahexaenoic acid
03
Conditions
Parenteral Nutrition Associated Liver Disease (PNALD)
Beyond the preview
Go deeper on NCT01191177.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01191177.